GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
16.9462 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TRPV1, TYR |
15.4555 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, EGFR, EPHX2, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, TRPV1 |
15.4555 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KCNH2, KDR, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TRPV1, XDH |
14.2192 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
13.8642 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IDO1, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TEK, TRPV1, TYR |
13.8642 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, ESRRA, FLT3, NR3C1, PTGS2, RORC, SLC6A3, SLC6A4, SRC, TEK, TRPV1, TYR |
13.6969 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EPHX1, EPHX2, FABP3, FUT7, GLO1, HSPA1A, IDO1, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, SOAT1, SOAT2, TYR, XDH |
12.7639 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP2, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TYR, XDH |
12.7639 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPR35, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
11.2811 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPR35, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
10.9758 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, EGFR, EPHX2, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SOAT1, SOAT2 |
10.8962 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESRRB, FABP4, HSD17B2, IDO1, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TRPV1, TYR |
10.8962 |
[BP] GO:0042592 |
homeostatic process
|
ADRA2A, AKR1B1, ALOX12, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, SOAT1, SOAT2, SRC, TERT, TRPV1 |
10.7091 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2, SOAT1, SOAT2 |
10.6388 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, PIK3CA, PIK3CB, SMAD3, SOAT1, SOAT2, TRPV1 |
10.2605 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADRA2A, AKR1B1, ALOX12, APP, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, FLT3, HSPA1A, IDO1, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGS1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.2605 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
10.1907 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
10.1579 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, EGFR, EPHX1, EPHX2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, TYR |
10.1105 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TRPV1 |
9.94666 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EPHX1, EPHX2, NQO2, PTGS1, RORC |
9.94121 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, NR3C1, PPARA, PTGS2, SLC6A4, SRC, TEK, TRPV1 |
9.94121 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
9.87444 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGS2, SLC6A3, SRC, TERT |
9.81314 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, SLC6A3, SOAT1, SOAT2, TYR |
9.58755 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, PTGS1, PTGS2 |
9.37023 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, PTGS1, PTGS2 |
9.05551 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
8.96383 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
8.93167 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
8.88707 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, PTGS1, PTGS2 |
8.86626 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EPHX1, EPHX2, KDR, SLC6A3, SLC6A4, SRC |
8.80815 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
8.75964 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
8.51936 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, DRD4, EGFR, FLT3, GPR35, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
8.4952 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, IDO1, NR3C1, PTGS2, RORC, SLC6A4, SRC, TYR |
8.45054 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CES1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TYR |
8.42006 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
8.35359 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, FABP3, KCNH2, KDR, NR3C1, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC, TRPV1 |
8.31011 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SMAD3, SRC, TRPV1 |
8.14629 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
7.94081 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESRRA, FABP4, FLT3, GPR35, HSPA1A, IDO1, INSR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
7.94081 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.9385 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.86441 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, XDH |
7.6814 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TERT, TOP2A, TRPV1 |
7.6814 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADRA2A, ADRA2C, ALOX12, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 |
7.67938 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD11B1, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH |
7.64013 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
7.62526 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, FABP3, PPARA, PTGS1, PTGS2 |
7.61151 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
7.40616 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, PTGS1, PTGS2 |
7.39349 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, EGFR, INSR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SMAD3, TRPV1 |
7.33523 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
7.30608 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A3, SLC6A4, SRC, TEK, TRPV1, TYR |
7.27824 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT |
7.2378 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
7.19593 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EGFR, EPHX2, HSPA1A, IDO1, SLC6A3 |
7.18529 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.07705 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.04077 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, ALOX12, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TEK, TERT |
7.00981 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IDO1, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
7.00382 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD3, DRD4, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.99028 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.95839 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, FABP3, GLO1, IDO1, PPARA, PTGS1, PTGS2 |
6.91961 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC, TOP2A |
6.88162 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.88162 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.88162 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD2, DRD3, DRD4, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SLC6A3, SLC6A4, SRC, TEK, TRPV1, TYR |
6.80808 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, NR3C1, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
6.80122 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, PTGS1, PTGS2 |
6.73382 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.58779 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
6.58317 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, ALOX12, APP, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.49723 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADRA2A, ADRA2C, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, DRD3, DRD4, EGFR, GPR35, HSPA1A, INSR, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
6.46785 |
[BP] GO:0030334 |
regulation of cell migration
|
ADRA2A, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.45734 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGS2, SLC6A3, TERT |
6.32085 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, PIK3CA, PPARA, SMAD3, SRC, TEK, TYR |
6.31696 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, ALOX12, APP, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.31438 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, HSPA1A, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK, TERT, TRPV1 |
6.26726 |
[BP] GO:0040012 |
regulation of locomotion
|
ADRA2A, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.26726 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, FLT3, GPR35, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
6.26726 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, ESRRB, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
6.26726 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
6.18572 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.18572 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, ALOX12, APP, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.18368 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD2, DUSP3, EGFR, EPHX2, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TEK, XDH |
6.18088 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
6.14652 |
[BP] GO:2000145 |
regulation of cell motility
|
ADRA2A, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
6.06682 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, ALOX12, APP, BCL2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.99198 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADRA2A, ALOX12, ALOX15, BCL2, CYP19A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TERT, XDH |
5.89941 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
5.88187 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.87408 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4, PTGS2, SLC6A4 |
5.86052 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, FABP3, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
5.84506 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.81693 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
5.7687 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DRD3, DRD4, EGFR, INSR, KCNH2, MMP12, PTGS2, SLC6A4, SMAD3, SRC, TERT, TRPV1 |
5.7687 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADRA2A, ADRA2C, ALOX15, APP, DRD2, DRD4, EGFR, FLT3, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
5.7687 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADRA2A, ADRA2C, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SLC6A4, SMAD3, SRC, TERT, XDH |
5.7487 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADRA2A, ADRA2C, ALOX12, APP, AXL, BCL2, CA2, CHRM2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, GPR35, HSPA1A, IDO1, INSR, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
5.74714 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.6784 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
5.65694 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.65109 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9, PTGS2 |
5.57 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADRA2A, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK, TERT |
5.56337 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, TYR |
5.50557 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.48942 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.46599 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADRA2A, ADRA2C, ALOX15, APP, DRD2, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, PIK3CB, PTPN1, SRC, TEK, XDH |
5.4527 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EPHX1, EPHX2, FABP3, FABP4, FUT7, HSPA1A, IDO1, MMP1, MMP12, MMP2, MMP9, PIK3CB, SLC6A3, SRC, XDH |
5.43767 |
[BP] GO:0080134 |
regulation of response to stress
|
ADRA2A, ALOX12, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IDO1, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.43767 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD4, EGFR, EPHX2, HSPA1A, IDO1, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1 |
5.41589 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.38328 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
5.33524 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.29497 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2 |
5.2848 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SOAT1, SRC, TEK, XDH |
5.26336 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
5.26336 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.26281 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
5.13217 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
5.12058 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, TRPV1 |
5.11696 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.10211 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, INSR, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SRC, TEK, TYR |
5.07985 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KCNH2, KDR, NR3C1, PTGS2, SRC, TRPV1 |
5.05634 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.04244 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
5.02883 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, APP, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, PTGS2, SLC6A4, SMAD3, SRC, TRPV1 |
5.02049 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HSD11B1, HSD17B1, HSD17B2 |
5.0195 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.95671 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.94248 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9 |
4.89141 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, RORC, SRC |
4.88022 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
4.77771 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, PTGS2, SLC6A3, SLC6A4, TEK, TRPV1, TYR |
4.77771 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
4.75733 |
[BP] GO:0030258 |
lipid modification
|
ALOX12, CYP1A1, CYP3A4, EGFR, EPHX2, MET, PIK3CA, PIK3CB, SOAT1, SOAT2 |
4.72656 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.69564 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.69066 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, IDO1, INSR, KDR, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, RORC, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
4.68751 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.66066 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.6408 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.64016 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TERT, TOP2A |
4.60058 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
4.60058 |
[BP] GO:0065009 |
regulation of molecular function
|
ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, TERT, TRPV1, XDH |
4.59495 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.59495 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADRA2A, AURKB, BCL2, CA2, CA7, DRD2, DRD3, EGFR, KDR, PIK3CB, PTGS2, SRC, TRPV1 |
4.59495 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9 |
4.5811 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.58094 |
[BP] GO:0040008 |
regulation of growth
|
ALOX12, APP, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIK3CA, PIM1, SLC6A3, SLC6A4, SMAD3 |
4.58094 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADRA2A, ADRA2C, APP, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.5767 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TERT, TOP2A |
4.53672 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EPHX2, FABP3, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.50326 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, PTGS2, RORC, SMAD3, SOAT1, SRC, TERT, TOP2A, TRPV1 |
4.49756 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
4.49363 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, PTGS2, SLC6A3, SLC6A4, TEK, TRPV1, TYR |
4.44981 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.44861 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
4.42898 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9 |
4.42898 |
[BP] GO:0097176 |
epoxide metabolic process
|
ALOX12, EPHX1, EPHX2 |
4.42898 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.42898 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.40095 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
4.37556 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
4.37375 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, EGFR, ESR1, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2, SLC6A3, SMAD3, TEK |
4.34953 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
4.33847 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
4.32688 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADRA2A, ADRA2C, APP, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
4.31345 |
[BP] GO:0051926 |
negative regulation of calcium ion transport
|
ADRA2A, BCL2, DRD2, DRD4, GPR35, PTGS2 |
4.30866 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK, TRPV1 |
4.28656 |
[BP] GO:0003018 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4, SRC, TEK |
4.28358 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, IDO1, INSR, MMP2, MMP9, PTGS2, SLC6A4, SRC, TOP2A |
4.26504 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR |
4.25536 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
4.24127 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, PIK3CA, SLC6A3 |
4.24126 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, ESR2, FLT3, HSPA1A, INSR, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.23745 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.23745 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADRA2A, ADRA2C, APP, AURKB, CDC25B, DRD2, DRD4, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.23745 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
4.197 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5, PTGS2 |
4.18496 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CES1, CYP19A1, CYP3A4, SLC6A3, TYR |
4.15864 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, FLT3, FUT7, GLO1, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SLC6A3, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.15006 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADRA2A, CYP1A1, DRD3, EPHX2, FABP3, FLT3, PPARA, PTGS2, RORC, SRC, TEK |
4.14484 |
[BP] GO:0003008 |
None
|
ADRA2A, ADRA2C, AKR1B1, APP, BCL2, CYP1B1, DRD2, DRD3, EGFR, EPHX2, INSR, KCNH2, PIK3CA, PTGS2, SLC6A3, SLC6A4, SOAT2, SRC, TEK, TRPV1, TYR |
4.1349 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADRA2A, ADRA2C, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
4.13001 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.11005 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PTGS2, RORC, SMAD3, SOAT1, SRC, TERT, TOP2A, TRPV1 |
4.10532 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
4.10532 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.10348 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
4.08035 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, IDO1, INSR, PPARA, PTGS2, SLC6A3, SLC6A4, TRPV1 |
4.06772 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
4.04655 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
4.03737 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, PPARA, TRPV1 |
4.03173 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, GPR35, KCNH2, PIK3CB, SMAD3, TRPV1 |
4.03173 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, EGFR, PTGS2, SLC6A4 |
4.02111 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, EGFR, PTGS2, SLC6A4 |
4.02111 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.01551 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
4.01551 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
4.01551 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
4.00775 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, DRD2, DRD4, EGFR, ESR1, FLT3, HSPA1A, INSR, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
4.00151 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.98451 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
3.97858 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.97643 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, BCL2, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, TERT, XDH |
3.97533 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADRA2A, APEX1, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
3.97126 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD2, DRD4, EGFR, PTGS2 |
3.96764 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ADRA2C, ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC, TRPV1 |
3.96328 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CA, PIK3CB, SMAD3, TRPV1 |
3.93484 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.93107 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
3.93107 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
3.89851 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADRA2A, ADRA2C, DRD2, DRD4, EGFR, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
3.88548 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR |
3.88542 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.88183 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.87929 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.86844 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC, TRPV1 |
3.8654 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
3.8654 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.8654 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.8654 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.8654 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.8654 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.8654 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
3.8654 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.84435 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, BCL2, CYP1B1, DUSP3, IDO1, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.84435 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.79625 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.78779 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.76711 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CA, PIK3CB, SMAD3, TRPV1 |
3.73498 |
[BP] GO:0051051 |
negative regulation of transport
|
ADRA2A, ADRA2C, APP, BCL2, DRD2, DRD3, DRD4, GPR35, HSPA1A, KCNH2, MMP9, PTGS2 |
3.73408 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADRA2A, ADRA2C, AURKB, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.73408 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADRA2A, ADRA2C, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
3.73408 |
[BP] GO:0031347 |
regulation of defense response
|
CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK |
3.73408 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.67955 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CDC25B, CES1, CYP1A1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, PTGS2, RORC, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A |
3.66336 |
[BP] GO:0098810 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.6472 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADRA2A, ADRA2C, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SLC6A3, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
3.64618 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, APP, AURKB, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
3.63824 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, IDO1, INSR, KDR, PIM1, PTGS2, SLC6A3, SMAD3, SRC, TEK, TERT |
3.63123 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC |
3.62748 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1, XDH |
3.61732 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADRA2A, ADRA2C, CDC25B, DRD2, DRD4, EGFR, FLT3, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
3.5964 |
[BP] GO:0043269 |
regulation of ion transport
|
ADRA2A, APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9, PTGS2, SLC6A4 |
3.59265 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SOAT1, SRC, TERT, TOP2A |
3.57685 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.57685 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PTGS2, SLC6A4, SRC, TRPV1 |
3.57685 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
3.57098 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.56396 |
[BP] GO:0003013 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4, SRC, TEK |
3.52836 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.52836 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
3.52836 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, KDR, PTPN1, SRC, TEK |
3.52836 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
3.49694 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.49694 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC, TRPV1 |
3.48901 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, CYP3A4, IDO1, PTGS1, PTGS2 |
3.4867 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.48004 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.48004 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.47713 |
[BP] GO:0008217 |
None
|
DRD2, DRD3, EPHX2, PPARA, PTGS1, PTGS2, SMAD3 |
3.45913 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, ALOX12, AOX1, APEX1, APP, BCL2, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, NR3C1, PPARA, PTGS2, RORC, SLC6A3, SMAD3, SOAT1, SOAT2, TERT, TOP2A, TYR, XDH |
3.45148 |
[BP] GO:0042752 |
None
|
DRD2, DRD3, DRD4, PPARA, RORC, TOP2A |
3.43418 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
3.40454 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TERT, TOP2A |
3.35684 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.35271 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, NR3C1, PTGS2, SRC |
3.34155 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.31931 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.31928 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.30822 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TEK, TYR |
3.29701 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
3.27617 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, PTGS1, PTGS2 |
3.26384 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, EGFR, PIK3CB, PTGS2 |
3.2568 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
3.24459 |
[BP] GO:0022898 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.23137 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, IDO1, INSR, KDR, PIM1, PTGS2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.21752 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.21558 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.18476 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, ADRA2C, AXL, PIK3CA, PIK3CB, SRC |
3.17344 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.15695 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.15695 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, BCL2, DRD2, DRD3, INSR, PIK3CA, PIM1, SLC6A3, SLC6A4 |
3.13538 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, EPHX2, ESR1, GPR35, PIK3CB, SMAD3, TRPV1 |
3.12519 |
[BP] GO:0051704 |
multi-organism process
|
ADRA2C, APP, AXL, BCL2, CHRM2, CYP1A1, DRD3, DRD4, EGFR, HSPA1A, IDO1, INSR, KDR, MET, MMP1, MMP12, SLC6A4, SMAD3, SRC |
3.12519 |
[BP] GO:0042632 |
None
|
EPHX2, FABP3, FABP4, SOAT1, SOAT2 |
3.12519 |
[BP] GO:0055092 |
None
|
EPHX2, FABP3, FABP4, SOAT1, SOAT2 |
3.12519 |
[BP] GO:0007194 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.10765 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA |
3.09544 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.09437 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, ADRA2C, AKR1B1, AXL, BCL2, CYP1B1, DRD2, DRD3, EGFR, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
3.08565 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR |
3.06693 |
[BP] GO:0032409 |
None
|
ADRA2A, APP, BCL2, DRD2, DRD3, DRD4, GPR35, MMP9 |
3.06693 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.06693 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, APP, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, MMP12, PTGS2, PTPN1, SMAD3, SRC, TERT |
3.06359 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.06359 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.0577 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EPHX1, EPHX2, FABP3, FABP4, HSPA1A, IDO1, PIK3CB, SLC6A3, SRC, XDH |
3.0577 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADRA2A, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 |
3.0523 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 |
3.04874 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.04874 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SLC6A4, SRC |
3.04038 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.04038 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, ALOX12, DRD2, MET, PIK3CA, TRPV1 |
3.03056 |
[BP] GO:0032148 |
None
|
ADRA2A, ADRA2C, INSR, SRC |
3.02554 |
[BP] GO:0031280 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
3.02554 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, INSR, PTGS2, SRC |
3.0155 |
[BP] GO:0090087 |
None
|
ACHE, ADRA2A, ADRA2C, APP, CA2, DRD2, DRD3, DRD4, EGFR, MMP12, PTGS2, PTPN1, SMAD3, SRC |
3.00628 |
[BP] GO:1900543 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
2.99942 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PIK3CB, PPARA, RORC, SLC6A4, SMAD3, SRC, TERT, TOP2A |
2.99332 |
[BP] GO:0045980 |
None
|
ADRA2A, DRD2, DRD3, DRD4, PPARA |
2.97413 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.97413 |
[BP] GO:0015872 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.9716 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2C19, CYP3A4 |
2.9716 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AURKB, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TRPV1 |
2.96997 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.96051 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.96051 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.96051 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.96051 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, APP, BCL2, DRD2, DRD3, DRD4, EGFR, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.95636 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.95531 |
[BP] GO:0051350 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.94971 |
[BP] GO:0045927 |
positive regulation of growth
|
ALOX12, BCL2, CSNK2A1, DRD2, EGFR, INSR, PIM1, SLC6A3 |
2.94711 |
[BP] GO:0097746 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4 |
2.94166 |
[BP] GO:0035296 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4 |
2.94166 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, PTGS2, SLC6A4 |
2.94166 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT |
2.9405 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.93395 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.925 |
[BP] GO:0044057 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, DRD3, EGFR, GPR35, KCNH2, PTGS2, SMAD3, TRPV1 |
2.9155 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.91197 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
2.90428 |
[BP] GO:0007193 |
None
|
ADRA2A, CHRM2, DRD2, DRD3, DRD4 |
2.8904 |
[BP] GO:0051952 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4 |
2.8904 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.88964 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.88964 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.88964 |
[BP] GO:0016125 |
None
|
APP, CES1, CYP19A1, CYP1B1, SOAT1, SOAT2 |
2.87691 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2, TERT |
2.87691 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.87513 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TRPV1, TYR |
2.86748 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC |
2.86094 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, PTGS2, SMAD3, SRC, TERT |
2.84434 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, EGFR, PTGS2, SLC6A4, TRPV1, TYR |
2.84434 |
[BP] GO:1901020 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.83489 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, BCL2, CA2, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9 |
2.81393 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADRA2A, ADRA2C, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SOAT1, SRC, TEK, XDH |
2.81146 |
[BP] GO:0050880 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4 |
2.81146 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80089 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.80089 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, PTGS1, PTGS2 |
2.80089 |
[BP] GO:0051254 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TOP2A |
2.80089 |
[BP] GO:0035150 |
None
|
ADRA2A, ADRA2C, EGFR, EPHX2, PTGS2, SLC6A4 |
2.7979 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, KDR, SRC, TEK |
2.79723 |
[BP] GO:0007165 |
signal transduction
|
ADRA2A, ADRA2C, AKR1B1, APP, AXL, BCL2, CA1, CA2, CHRM2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
2.79462 |
[BP] GO:0051241 |
negative regulation of multicellular organismal process
|
ADRA2C, ALOX12, APP, AXL, BCL2, DRD2, DRD3, EGFR, GPR35, IDO1, PTGS2, SLC6A4, SMAD3, TEK, TERT, XDH |
2.76782 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PTGS2, TYR |
2.75523 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3, TRPV1 |
2.75523 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, PPARA, RORC, SLC6A4 |
2.74923 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, APP, CES1, CYP1B1, CYP3A4, SOAT1, SOAT2 |
2.74135 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, PTGS2, SRC, TEK, TRPV1 |
2.72011 |
[BP] GO:0051937 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.71731 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.71731 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD2, DRD3, PPARA, SLC6A3, SMAD3, TEK |
2.7129 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
2.7129 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.71237 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, EPHX2, HSPA1A, IDO1, SLC6A3, XDH |
2.71101 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, NR3C1, PTGS2 |
2.70559 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
2.70244 |
[BP] GO:1903170 |
None
|
ADRA2A, DRD2, DRD4, GPR35 |
2.69081 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.69081 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.68762 |
[BP] GO:0042058 |
None
|
ADRA2A, ADRA2C, APP, EGFR, MMP9 |
2.6716 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, DRD3, EGFR, PTGS2, TYR |
2.658 |
[BP] GO:0030818 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.65652 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, APP, AXL, BCL2, CA2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HSPA1A, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC |
2.64838 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.64838 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.64838 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, TERT |
2.64838 |
[BP] GO:0018904 |
None
|
ALOX12, EPHX1, EPHX2 |
2.64838 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, KCNH2, MMP9 |
2.64489 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC, TERT |
2.63782 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.62585 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, ADRA2C, APP, DRD2, DRD3, DRD4, EGFR, MMP12, PTGS2, PTPN1, SMAD3, SRC |
2.61841 |
[BP] GO:0009410 |
None
|
DRD2, DRD3, DRD4, EGFR, NR3C1, SLC6A3 |
2.60477 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, SLC6A3, SLC6A4 |
2.59147 |
[BP] GO:0030803 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.59147 |
[BP] GO:0045893 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TOP2A |
2.58489 |
[BP] GO:1903508 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TOP2A |
2.58489 |
[BP] GO:1902680 |
None
|
APP, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TOP2A |
2.5818 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX12, ALOX15, CYP1A1, IDO1, PTGS1, PTGS2 |
2.57731 |
[BP] GO:1901386 |
None
|
DRD2, DRD4, GPR35 |
2.57731 |
[BP] GO:0001504 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.57731 |
[BP] GO:0051047 |
None
|
ACHE, CYP19A1, DRD2, DRD3, EGFR, MMP12, SLC6A4, SRC, TRPV1 |
2.57731 |
[BP] GO:0034435 |
None
|
SOAT1, SOAT2 |
2.57731 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.57731 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.57731 |
[BP] GO:0034433 |
None
|
SOAT1, SOAT2 |
2.57731 |
[BP] GO:0034434 |
None
|
SOAT1, SOAT2 |
2.57731 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57731 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.57731 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57731 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.57731 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.57731 |
[BP] GO:0050433 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3 |
2.57545 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PIK3CB, PTPN1, SRC |
2.56229 |
[BP] GO:0030815 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.54088 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CYP19A1, EGFR, ESR1, FABP4, IDO1, PPARA, PTGS2, SMAD3, TEK |
2.53339 |
[BP] GO:0032412 |
None
|
ADRA2A, APP, DRD2, DRD3, DRD4, GPR35, MMP9 |
2.52769 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, KCNH2, PPARA, SLC6A2, SLC6A3, SLC6A4, TRPV1 |
2.50968 |
[BP] GO:1900372 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.50966 |
[BP] GO:0030809 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.50966 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, KDR, PTGS2, TEK, TERT |
2.50571 |
[BP] GO:0051591 |
None
|
APEX1, APP, SLC6A3, TEK, TYR |
2.48706 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.48706 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, IDO1, MMP12, PTGS2, SMAD3, SRC |
2.48078 |
[BP] GO:0030800 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.47917 |
[BP] GO:0007188 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, DRD3, DRD4 |
2.47888 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
APP, BCL2, CYP1B1, DRD2, FABP3, HSPA1A, IDO1, PTGS2, SLC6A4, SMAD3, TERT, XDH |
2.46812 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.45468 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MMP9, PTGS2, PTPN1, SRC |
2.4508 |
[BP] GO:2001258 |
None
|
DRD2, DRD4, GPR35, MMP9 |
2.44937 |
[BP] GO:0050730 |
None
|
ADRA2A, ADRA2C, APP, EGFR, FLT3, PTPN1, SRC |
2.43263 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, PTGS2, SLC6A3, TERT |
2.43263 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, BCL2, EGFR, PIK3CA, PTGS2 |
2.43263 |
[BP] GO:1901184 |
None
|
ADRA2A, ADRA2C, APP, EGFR, MMP9 |
2.43263 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.42025 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, EGFR, PTGS2, SLC6A4, SRC, TRPV1, TYR |
2.40808 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, PTPN1, SRC |
2.40377 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.40212 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.40109 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.40109 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.40109 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.40109 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.40109 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.40109 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.40109 |
[BP] GO:0007611 |
None
|
APP, DRD2, DRD3, EGFR, INSR, PTGS2, SLC6A4 |
2.39904 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.39904 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.38647 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.37269 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.37269 |
[BP] GO:0033555 |
multicellular organismal response to stress
|
BCL2, DRD4, IDO1, SLC6A2 |
2.37269 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.37269 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.34512 |
[BP] GO:0015844 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.34512 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.34456 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD2, DRD3, DRD4, ESRRB, INSR, PPARA |
2.3409 |
[BP] GO:0098657 |
import into cell
|
ACHE, ALOX15, APP, AXL, DRD2, DRD3, SLC6A2, SLC6A3, SLC6A4, TRPV1 |
2.33287 |
[BP] GO:0051046 |
None
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MMP12, SLC6A4, SRC, TRPV1 |
2.32633 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.32633 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.32633 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.32633 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.32633 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.32633 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.32397 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.32391 |
[BP] GO:0031348 |
negative regulation of defense response
|
CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.29871 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.29834 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.29834 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29834 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MMP12, SRC |
2.29232 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR3C1, PPARA, PTGS2, PTPN1, RORC, SMAD3, SRC, TERT, TRPV1, XDH |
2.28475 |
[BP] GO:0055088 |
None
|
EPHX2, FABP3, FABP4, SOAT1, SOAT2 |
2.25573 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, MET, PIK3CA, PIK3CB |
2.25366 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
ALOX12, CYP1B1, KDR, PTGS2, TEK, TERT |
2.25219 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
ADRA2A, ALOX12, APP, AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK |
2.24957 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.24957 |
[BP] GO:0051953 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.24957 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.24957 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.24957 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.24957 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24957 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MMP9, NUAK1, PTGS2, PTPN1, SRC, TERT, TOP2A, TRPV1 |
2.23712 |
[BP] GO:0019229 |
None
|
ADRA2A, ADRA2C, EGFR, PTGS2 |
2.22494 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.22089 |
[BP] GO:0007626 |
None
|
APP, DRD2, DRD3, DRD4, IDO1, SLC6A3 |
2.20875 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.20875 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK, TOP2A |
2.20875 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, APEX1, EGFR, ESR1, FLT3, INSR, NR3C1, SRC |
2.20506 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.20399 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.20399 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.20399 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.20399 |
[BP] GO:0071875 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.20399 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20399 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2C19, CYP3A4, SLC6A3 |
2.20135 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, NUAK1, PTGS2, PTPN1, TERT, XDH |
2.19841 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, BCL2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, PTGS2, PTPN1, SMAD3, SRC, TERT |
2.19253 |
[BP] GO:1902652 |
None
|
APP, CES1, CYP3A4, SOAT1, SOAT2 |
2.1879 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
ADRA2A, APP, CSNK2A1, DRD2, DRD3, DRD4, DUSP3, FABP4, IGF1R, MMP9, PTGS2, PTPN1, SRC |
2.18577 |
[BP] GO:0051253 |
None
|
APEX1, AURKB, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TERT, TRPV1 |
2.18543 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD4 |
2.18543 |
[BP] GO:0007187 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, DRD3, DRD4 |
2.17204 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.17204 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, PIK3CB, PPARA, PTPN1 |
2.16603 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADRA2A, BCL2, EGFR, MET, PIK3CA, PPARA, SMAD3 |
2.15386 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADRA2A, DRD4, EGFR, FLT3, INSR, PIK3CB, PTPN1, SRC |
2.1534 |
[BP] GO:0045595 |
regulation of cell differentiation
|
ADRA2C, APP, AXL, BCL2, CA2, DRD2, DRD3, EGFR, ESRRA, ESRRB, KDR, PPARA, PTGS2, RORC, SLC6A4, SMAD3, TERT, TRPV1, XDH |
2.15237 |
[BP] GO:0035624 |
None
|
ADRA2A, ADRA2C |
2.15237 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.15237 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.15237 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.15237 |
[BP] GO:0014060 |
None
|
ADRA2A, ADRA2C |
2.15237 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, IDO1, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.14935 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, DRD2, PTGS2, SLC6A4 |
2.14712 |
[BP] GO:0008150 |
biological_process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
2.14712 |
[BP] GO:0046394 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, IDO1, PTGS1, PTGS2 |
2.13819 |
[BP] GO:0045596 |
None
|
APP, BCL2, DRD3, EGFR, ESRRB, PPARA, SLC6A4, SMAD3, TERT, TRPV1, XDH |
2.13819 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.13819 |
[BP] GO:0050776 |
regulation of immune response
|
ALOX15, BCL2, DRD2, DUSP3, ESR1, HSPA1A, IDO1, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC |
2.13819 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.13657 |
[BP] GO:0010959 |
None
|
ADRA2A, BCL2, DRD2, DRD3, DRD4, GPR35, KCNH2, PTGS2 |
2.13657 |
[BP] GO:0002791 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, DRD3, DRD4, EGFR, MMP12, SRC |
2.13504 |
[BP] GO:0016053 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, IDO1, PTGS1, PTGS2 |
2.13467 |
[BP] GO:0006869 |
None
|
DRD2, DRD3, DRD4, FABP3, PPARA, SOAT1, SOAT2 |
2.13467 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, EGFR, ESR1, FLT3, NR3C1, RORC, SLC6A4, SRC |
2.13467 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.13467 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.13467 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.13467 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.13467 |
[BP] GO:0006693 |
None
|
CES2, PTGS1, PTGS2 |
2.13467 |
[BP] GO:0006692 |
None
|
CES2, PTGS1, PTGS2 |
2.13467 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13467 |
[BP] GO:0006940 |
None
|
ADRA2A, ADRA2C, CHRM2, PTGS2 |
2.13467 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.13394 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
ADRA2A, APEX1, BCL2, ESRRB, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.12727 |
[BP] GO:0000122 |
None
|
AURKB, DRD3, ESR1, ESR2, ESRRA, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, TRPV1 |
2.12286 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADRA2A, ADRA2C, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
2.11981 |
[BP] GO:0010675 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.11981 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSD17B2, INSR, SRC |
2.11431 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.11431 |
[BP] GO:0006357 |
None
|
APP, AURKB, CA9, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, GLO1, HSPA1A, MET, MMP12, NR3C1, PPARA, RORC, SMAD3, TERT, TOP2A, TRPV1 |
2.1111 |
[BP] GO:0050890 |
None
|
APP, DRD2, DRD3, EGFR, INSR, PTGS2, SLC6A4 |
2.09724 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
APP, AXL, BCL2, CA1, CSNK2A1, DRD2, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, TRPV1 |
2.09429 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.09364 |
[BP] GO:0051705 |
None
|
APP, DRD3, DRD4, SLC6A4 |
2.09364 |
[BP] GO:0009888 |
tissue development
|
ALOX15, ALPL, CYP1B1, INSR, KDR, PIK3CA, PPARA, PTGS2, RORC, SMAD3 |
2.08996 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, DRD2, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.0732 |
[BP] GO:0045913 |
None
|
ESRRB, INSR, PPARA, SRC |
2.07141 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.07141 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADRA2A, ADRA2C, CYP19A1, DRD2, DRD3, DRD4, EGFR, MMP12, SLC6A4, SRC |
2.06143 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.05568 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.05229 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, IDO1, KDR, MET, PTGS2, SMAD3 |
2.03931 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, BCL2, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SLC6A4, SMAD3, SRC, TEK |
2.0385 |
[BP] GO:1903507 |
None
|
APEX1, AURKB, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TRPV1 |
2.02869 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.02869 |
[BP] GO:1902679 |
None
|
APEX1, AURKB, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, NR3C1, PPARA, RORC, SMAD3, SRC, TRPV1 |
2.02269 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.02266 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.02266 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.02266 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.02266 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.02266 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.02266 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.02266 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.02266 |
[BP] GO:0051590 |
None
|
DRD2, DRD4, SLC6A4 |
2.02266 |
[BP] GO:0007176 |
None
|
ADRA2A, ADRA2C, APP |
2.02266 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.02266 |
[BP] GO:0015850 |
None
|
SLC6A2, SLC6A3, SLC6A4, SOAT1, SOAT2 |
2.01956 |
[BP] GO:0016311 |
None
|
ALPL, APEX1, BCL2, CDC25B, DUSP3, EPHX2, PTPN1 |
2.00899 |
[BP] GO:1903522 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2, EGFR, KCNH2, PTGS2 |
2.00101 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, INSR, KCNH2, KDR, MMP2, MMP9, NQO2, NR3C1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TERT, TOP2A, TRPV1, TYR, XDH |
5.0063 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC, TEK |
4.10502 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC, TEK |
4.08176 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR, EPHX1, FLT3, HSD11B1, HSD17B2, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2 |
4.02824 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADRA2A, ADRA2C, ALOX12, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD2, DRD3, DRD4, EGFR, ESR1, FLT3, GLO1, GPR35, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC6A2, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TERT, TRPV1 |
4.02111 |
[CC] GO:0016020 |
membrane
|
ACHE, ADRA2A, ADRA2C, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EGFR, EPHX1, ESR1, FLT3, FUT7, GLO1, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TRPV1, TYR |
3.88183 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC, TEK |
3.49432 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADRA2A, ADRA2C, APP, AXL, CA4, CHRM2, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, SLC6A4, TEK, TRPV1 |
3.31295 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADRA2A, ADRA2C, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, ESR1, FLT3, FUT7, GPR35, HSD11B1, HSD17B2, IGF1R, INSR, KCNH2, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A3, SLC6A4, SOAT1, SOAT2, SRC, TEK, TRPV1, TYR |
3.29701 |
[CC] GO:0044459 |
plasma membrane part
|
ADRA2A, ADRA2C, ALOX15, APP, AXL, CA2, CA4, CA9, CHRM2, DRD2, DRD3, DRD4, DUSP3, EGFR, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PTGS2, SLC6A2, SLC6A3, SLC6A4, SRC, TEK, TRPV1 |
3.08157 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADRA2A, ADRA2C, APP, AXL, CHRM2, DRD2, DRD3, DRD4, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A3, SLC6A4, TEK, TRPV1 |
3.05354 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR, EPHX1, HSD11B1, HSD17B2, PTGS1, PTGS2, SOAT1, SOAT2 |
3.03577 |
[CC] GO:0005783 |
None
|
APEX1, APP, BCL2, CA4, CES1, CES2, CYP19A1, FLT3, HSPA1A, KDR, PTGS2, PTPN1, SOAT1, SOAT2, XDH |
2.94201 |
[CC] GO:0044464 |
cell part
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
2.71038 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DUSP3, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SOAT1, SOAT2, SRC, TERT, TOP2A, TYR, XDH |
2.3787 |
[CC] GO:0098793 |
None
|
ADRA2C, APP, CHRM2, DRD2, SLC6A3, SLC6A4 |
2.35535 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, KCNH2, MET, SLC6A2, SLC6A3, TEK |
2.19606 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.14712 |
[CC] GO:0044424 |
intracellular part
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
2.11013 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.02266 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EGFR, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
17.0508 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
16.9462 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DUSP3, EGFR, EPHX1, EPHX2, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TYR, XDH |
12.7639 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, TERT, TOP2A, TRPV1, TYR, XDH |
11.6788 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.82452 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, SLC6A3, SLC6A4, SRC, TEK, TOP2A, TRPV1 |
9.76615 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EPHX2, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, TERT, TOP2A, TRPV1, TYR, XDH |
9.58755 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD11B1, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH |
9.17848 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, NR3C1, RORC, SOAT1, SOAT2 |
8.51936 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, PPARA, PTPN1, RORC, SMAD3 |
7.61151 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, XDH |
7.27149 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD2, DRD3, DRD4, SLC6A3 |
7.07705 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, IDO1, PTGS1, PTGS2, SRC |
7.00981 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, APP, BCL2, CSNK2A1, DRD2, DRD4, EGFR, EPHX2, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MET, MMP9, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TRPV1, TYR, XDH |
7.00981 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.99028 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, SOAT1, SOAT2, SRC, XDH |
6.88162 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, IDO1, PTGS1, PTGS2, SRC |
6.76111 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.39312 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.24533 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.97252 |
[MF] GO:0038023 |
signaling receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
5.88413 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
5.78352 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADRA2A, ADRA2C, AOX1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
5.67034 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, PTGS1, PTGS2, TYR |
5.26281 |
[MF] GO:0016803 |
ether hydrolase activity
|
ALOX12, ALOX15, EPHX1, EPHX2 |
5.13217 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4 |
5.11285 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.10211 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HSD17B1, NR3C1, PPARA, RORC, SOAT1, SOAT2, TRPV1 |
5.07069 |
[MF] GO:0004872 |
receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
5.0195 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A3, SLC6A4, SMAD3, SRC |
4.97185 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.92847 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.92847 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
4.92394 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, BCL2, DRD2, EPHX2, FLT3, KCNH2, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
4.92172 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SLC6A3, SLC6A4, SMAD3, SRC |
4.92172 |
[MF] GO:0004871 |
signal transducer activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, SMAD3, TEK, TRPV1 |
4.87732 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.87436 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS2 |
4.87436 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2, NR3C1 |
4.83208 |
[MF] GO:0060089 |
molecular transducer activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
4.8043 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
4.79771 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS2 |
4.79685 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.77771 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
4.72595 |
[MF] GO:0016801 |
None
|
ALOX12, ALOX15, EPHX1, EPHX2 |
4.65162 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.58094 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, TYR |
4.56034 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.5266 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
4.34416 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
4.23745 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2C19, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, HSPA1A, KCNH2, MET, NR3C1, PPARA, PTGS2, PTPN1, SLC6A3, SLC6A4, SMAD3, SRC, TEK, TOP2A |
4.1349 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3, SLC6A4 |
4.05709 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.93107 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.8654 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TERT |
3.70021 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, XDH |
3.67955 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADRA2A, ADRA2C, AOX1, AXL, BCL2, DRD2, EGFR, EPHX2, FLT3, KCNH2, NQO2, PTGS2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
3.65573 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS1, PTGS2 |
3.61732 |
[MF] GO:0051379 |
None
|
ADRA2A, ADRA2C, DRD4 |
3.48004 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.48004 |
[MF] GO:0008504 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
3.31958 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.31958 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.31958 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SLC6A3, SMAD3 |
3.21467 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2C19, CYP3A4 |
3.02554 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SOAT1, SOAT2, SRC, TEK, TOP2A, TRPV1, XDH |
2.9764 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
2.9716 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.96051 |
[MF] GO:0034736 |
None
|
SOAT1, SOAT2 |
2.96051 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.96051 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.96051 |
[MF] GO:0004772 |
None
|
SOAT1, SOAT2 |
2.96051 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SOAT1, SOAT2, SRC, TEK, TOP2A, TRPV1, XDH |
2.86748 |
[MF] GO:1901363 |
heterocyclic compound binding
|
AOX1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD17B1, HSPA1A, IDO1, IGF1R, INSR, KDR, MET, MMP12, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TRPV1, XDH |
2.67433 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.65652 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.64838 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.57731 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.57731 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.57731 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.57731 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.57731 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.57731 |
[MF] GO:0005328 |
None
|
SLC6A2, SLC6A3, SLC6A4 |
2.40109 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.40109 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.39531 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.32633 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.32633 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.32633 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.32633 |
[MF] GO:0008227 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2 |
2.29834 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.29052 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, TRPV1 |
2.256 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.23958 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADRA2A, ADRA2C, AXL, CHRM2, DRD2, DRD3, DRD4, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.23958 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
2.18905 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, TRPV1, XDH |
2.1879 |
[MF] GO:0005102 |
receptor binding
|
ADRA2A, ADRA2C, APP, DRD2, DRD3, EGFR, EPHX2, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, KDR, PTPN1, SLC6A3, SMAD3, SRC |
2.18543 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.16128 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.15237 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.15237 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15237 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.15237 |
[MF] GO:0051380 |
None
|
ADRA2A, DRD4 |
2.15237 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, MET, PTPN1, SLC6A3 |
2.15108 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.13819 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP3A4, DRD2, DRD3, DRD4, DUSP3, EGFR, EPHX1, EPHX2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IDO1, IGF1R, INSR, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A3, SLC6A4, SMAD3, SOAT1, SOAT2, SRC, TEK, TERT, TOP2A, TRPV1, TYR, XDH |
2.13819 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.11431 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.09364 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.05229 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.05019 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, NR3C1, PTPN1, SMAD3, SRC, TOP2A |
2.02575 |
[MF] GO:0004936 |
None
|
ADRA2A, ADRA2C |
2.02266 |
[MF] GO:0055131 |
None
|
HSPA1A, KCNH2 |
2.02266 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02266 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.02266 |
[MF] GO:0004301 |
None
|
EPHX1, EPHX2 |
2.02266 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.02266 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.02266 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.00531 |